Related Experiment Video
Updated: Sep 16, 2025
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
34.7K
Current Status of Cryoablation in Prostate Cancer Management
Jakub Karwacki1,2, Justyna Kiełbasa1,3, Zuzanna Szczepaniak1,4
1Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wrocław, Poland.
Clinical Medicine Insights. Oncology
|July 7, 2025
Summary
Cryoablation offers a minimally invasive prostate cancer (PCa) treatment balancing oncological control and quality of life. While promising, more research, including randomized controlled trials, is needed to establish definitive recommendations for focal and whole-gland cryoablation.
Area of Science:
- Urology
- Oncology
- Minimally Invasive Surgery
Background:
- Prostate cancer (PCa) management increasingly explores minimally invasive options.
- Cryoablation is emerging as a technique for PCa treatment, aiming for oncological efficacy and functional preservation.
Purpose of the Study:
- To review current evidence on focal and whole-gland cryoablation for prostate cancer.
- To provide an overview of clinical applications, outcomes, and future directions.
Main Methods:
- Narrative review of existing literature on cryoablation for PCa.
- Analysis of oncological and functional outcomes for both focal and whole-gland approaches.
Main Results:
- Focal cryoablation shows potential for patients prioritizing functional outcomes.
- Whole-gland cryoablation may suit intermediate- and high-risk PCa requiring complete ablation.
- Significant heterogeneity exists in current data, limiting definitive conclusions.
Conclusions:
- Cryoablation is a promising minimally invasive treatment for PCa.
- Further high-quality studies, especially randomized controlled trials, are essential.
- Clarifying the optimal role of cryoablation in PCa treatment requires more evidence.
